… virus (AAV) vector-based gene therapy, has continued to show safety … to treatment with the gene therapy, and that GCase expression … range following treatment with the gene therapy. Although, they noted … trial of FLT201 AAV gene therapy in adult patients with …

… review timeline of the new gene therapy. The classification will also allow … potentially provide this novel modifier gene therapy candidate to all RP patients … Medicinal Product Classification for Modifier Gene Therapy Candidate OCU400 for Retinitis Pigmentosa …

… moratorium on the administration of gene therapy products for infectious disease indications … pause the use of experimental gene therapy shots while we further assess … . This bill only applies to gene therapy for infectious disease indications (immunizations …

… in the European Union. The gene therapy, named etuvetidigene autotemcel, was developed … (EMA) for evaluating the gene therapy. Etuvetidigene autotemcel is designed as … combined immunodeficiency (ADA-SCiD). That gene therapy also originated in the laboratories …

… . The treatment is the first gene therapy for this aggressive brain cancer … , a surgical procedure for administering gene therapy. USC investigators are developing a … laboratory model outcomes. Cell & Gene Therapy coverage on Pharmaceutical Technology is …

… certification programs on cell and gene therapy biomanufacturing, biotechnology and biopharmaceuticals. These …

… treating HPP will be a gene therapy in which a single … safety and effectiveness of a gene therapy for HPP. The new … including different dosages of the gene therapy, tests in male and female … rather than infants, the gene therapy was more effective on female …

… and effectiveness of a gene therapy for HPP. The new … including different dosages of the gene therapy, tests in male and … rather than infants, the gene therapy was more effective on female … enzymatic activity spurred by the gene therapy. In adult female mice …

… , an adeno-associated virus (AAV) gene therapy candidate for Gaucher disease type … an adeno-associated virus (AAV) gene therapy candidate in clinical development as … a potential first-in-class gene therapy candidate for adrenomyeloneuropathy, as well …

… treatment would be the first gene therapy for glioblastoma to use a … the tumor to deliver the gene therapy and cellular treatment. This clinical …